Tisch MS News

Massimiliano Cristofanilli, PhD (Tisch MS) presented the following article in Journal Club.

Article title: CXCR4 Signaling Regulates Remyelination by Endogenous Oligodendrocyte Progenitor Cells in a Viral Model of Demyelination

Reference: Carbajal KS, Miranda JL, Tsukamoto MR and Lane TE. GLIA 2011 December; Volume 59, Issue 12,pages 1813–1821.

Rain or shine or even snow can't stop us from holding our annual symposium. We had another great patient symposium this year. We want to thank everyone that came out and participated. A special commendation to our symposium committee. We have received great feedback about the talks given by the clinicians and updates about our research in MS. Participants were able to meet our lead scientists and discuss about the 8 posters presented at the 2011 ECTRIMS+ACTRIMS meeting. Thank you all for coming!

Massimiliano Cristofanilli, PhD (Tisch MS) presented the following article in Journal Club.

Article title: CXCR4 Signaling Regulates Remyelination by Endogenous Oligodendrocyte Progenitor Cells in a Viral Model of Demyelination

Reference: Carbajal KS, Miranda JL, Tsukamoto MR and Lane TE. GLIA 2011 December; Volume 59, Issue 12,pages 1813–1821.

Dr. André Müeller gave a platform presentation titled “MS Disease Activity Inhibits Hepatocyte Growth Factor (HGF) Production Within the CNS – A New Putative Mechanism Contributing to Lack of Lesion Repair Seen in MS”at the 2011 meeting of the Society for Neuroscience in Washington DC. The cytokine Hepatocyte Growth Factor (HGF) is known to possess neuroprotective and anti-inflammatory properties, to enhance axonal outgrowth, and to promote oligodendrocyte maturation. Dr.

Armistead Williams, MD (Tisch MS) presented the following article in Journal Club.

Article title: Hygiene Hypothesis and Autoimmune Disease

Reference: Graham A. W. Rook. Clinic Rev Allerg Immunol. November 2011 DOI 10.1007/s12016-011-8285-8

Raihan Faroqui (Tisch MS) presented the following article in Journal Club.

Article title:  Triiodothyronine Administration Ameliorates the Demyelination/Remyelination Ratio in a Non-Human Primate Model of Multiple Sclerosis by Correcting Tissue Hypothyroidism